Linkus ORVI granules

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

salix alba, adhatoda vasika, glycyrrhiza glabra, viola odorata, valeriana officinalis, foeniculum vulgare, eucalyptus globulus, thea sinensis

Available from:

Herbion Pakistan Pvt. Ltd.

ATC code:

R05CA10

INN (International Name):

salix alba, adhatoda vasika, glycyrrhiza glabra, viola odorata, valeriana officinalis, foeniculum vulgare, eucalyptus globulus, thea sinensis

Dosage:

750mg+ 300mg+ 550mg+ 100mg+ 100mg+ 75mg+ 35mg+ 125mg

Pharmaceutical form:

granules

Units in package:

(5) sachets, (10) sachets

Prescription type:

OTC

Authorization status:

Registered

Authorization date:

2019-06-19

Summary of Product characteristics

LINKUS ORVI GRANULES
BRIEF CHARACTERISTIC OF MEDICAL PREPARATION
1.
NAME OF PREPARATION
Linkus ORVI
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
EACH SACHET CONTAINS EXTRACT FROM:
_Active ingredients: _
Salix alba
750.00 mg
Adhatoda vasica 300.00 mg
Viola odorata 100.00 mg
Glycyrrhiza glabra 550.00 mg
Thea sinensis (Tea leaves) 125.00 mg
Foeniculum vulgare 75.00 mg
Eucalyptus globulus 35.00 mg
Valeriana officinalis 100.00 mg
_FOR EXCIPIENTS, SEE 6.1. _
3.
MEDICINAL FORM
Granules;
4.
CLINICAL CHARACTERISTICS
4.1.
THERAPEUTIC INDICATIONS
Symptomatic therapy for acute respiratory viral infections (ARVI)
(fever (up to 38 ° C),
headache, nasal congestion, soreness in swallowing, cough).
DOSAGE AND ADMINISTRATION
For oral use;
Adults - 1 sachet 2-3 times a day after meals.
Dissolve one sachet in a cup of hot water or tea and sip slowly
Duration of treatment course: 7 - 8 days
.
4.2.
CONTRAINDICATIONS:
Pregnancy and lactation
,
children
below 18 years.
4.3.
SPECIAL INSTRUCTIONS AND SPECIAL SAFETY MEASURES
The granules contains sucrose, which should be taken in account prior
to use in diabetic
patients and patients on low caloric diet.
Use the drug with caution In patients with impaired liver, renal
function, cardiovascular
system, increased blood clotting. _ _
_ _
_ _
_ _
4.4.
DRUG OND OTHER FORMS OF INTERACTIONS:
Concomitant
use
with
other
antitussive
preparations
and
preparations
which
decrease
expectorations is not recommended because this makes it difficult to
cough up diluted
sputum
4.5. IMPACT ON ABILITY TO DRIVE OR PERFORMING HAZARDOUS TASKS:
Not revealed.
4.6.
SIDE EFFECTS:
Allergy is possible in individuals with known hypersensitivity to any
of the components of
Linkus ORVI.
4.7.
OVER DOSAGE:
Not revealed.
5.
PHARMACOLOGICAL PROPERTIES
5.1.
PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES
Herbal Linkus ORVI granules are optimally balanced composition of
carefully selected
plants with analgesic, antipyretic, expectorant and decongestant
effect.
Collectively they possess a broad spectrum antimicrobial action and
pr